We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene for Drug Abuse Identified

By Biotechdaily staff writers
Posted on 22 May 2002
Researchers have been able to identify a gene that increases risk for use and dependence on drugs. More...
In a study appearing in the March 2002 issue of the Journal of Molecular Psychiatry, they report that the mu-opoid gene brings about increased risk for use and abuse of drugs in general and does not appear to be specific for any particular drug.

The new study followed up on work done in 1999 that found a relationship between alcohol dependence and the mu-opoid gene. By comparing gene patterns between alcoholics and normal volunteers, they discovered that alcoholics had an abundance of a particular form of the mu-opioid gene, the AA form, compared to non-alcoholics. However, since many alcoholics included in the 1999 study were also abusers of other substances, the researchers could not conclude that this particular gene configuration conferred increased risk specific to alcoholism or to drug abuse in general.

"The 1999 study suggested that mu-opioid was a part of the drug abuse story, but did not allow us to ask more specific questions about relationships to other drugs or the gene's impact in other groups such as smokers or social drinkers,” said Dr. John Schinka, professor of psychiatry at the University of South Florida (Tampa, USA).
"In the current study, we looked at several groups, including a group of normal volunteers who had never been smokers or drinkers and a group of alcoholics who also used other drugs.”

The new research showed that the AA configuration occurred even in individuals with no history of smoking or drinking. However, the frequency of the configuration increased in groups with any use of alcohol or cigarettes and occurred in almost 90% of individuals treated for abuse of several drugs. Dr. Schinka emphasized that mu-opioid is only one of several genes that produce risk for drug abuse. The search for other genes will continue, and studies will also address how mu-opioid might interact with other genes in increasing risk.

University of South Florida >> www.usf.edu



Related Links:
University of South Florida

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.